The First New Treatment For Parkinson's Disease In Over 50 Years

About this Event

BioVie [NASDAQ: BIVI] is a biopharmaceutical company focusing on treating diseases caused by inflammation.

BioVie’s lead program is an orally available treatment called Bezisterim, which has shown promising results in reducing inflammation and insulin resistance, improving motor control and symptoms in Parkinson’s Disease. It also improves cognition and brain imaging scans in Alzheimer’s Disease.

BioVie sees potential in the Alzheimer’s and Parkinson’s markets, with projected annual sales of $30 billion and $3 billion respectively. The company has a strong leadership team with expertise in biopharma and technology.

Watch the webinar with BioVie President & CEO, Cuong Do, to hear how their experienced team has developed an anti-inflammation platform that has the potential to treat Parkinson’s, Alzheimer’s, Liver disease, Diabetes, Arthritis and more.

Hosted by Steven Saltzstein, CEO, Force Family Office

Video On Demand

– Recorded

June 27


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.